We show that intravitreal Bevacizumab treatment for macular edema induced by BRVO leads to a fast and significant improvement of visual acuity and a concurrent decrease of CRT. Similar results ...

Outside the United States, Lucentis is approved in more than 120 countries to treat adult patients with wet AMD, and for the treatment of visual impairment due to DME, due to macular edema secondary ...

In conclusion, data from high-quality RCTs for ranibizumab and dexamethasone IVT have demonstrated that both new agents have promising outcomes for the treatment of BRVO and CRVO, and constitute ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Some retinal thickening at the site of BRVO along the IT arcade was also noted ... oral steroids alone can be effective in reducing the perivenous cuffing, exudation and macular oedema, as we saw in ...

Background/aims To describe clinical and multimodal imaging features in a cohort of choroidal macrovessels. Methods Demographics and multimodal imaging features of 16 eyes of 13 patients with ...

Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one. Macular degeneration, also known as age-related macular degeneration ...